Tylenol Autism Lawsuit Calculator
MDL 3043 (S.D.N.Y.) — REVIVED on appeal: on July 13, 2026 the Second Circuit (Rutledge v. Walgreen Co.) vacated the exclusion of three of the plaintiffs' five expert witnesses and sent more than 500 dismissed cases back to Judge Cote. No trial date, no settlement, and the defense has since filed a request asking the Second Circuit to revisit its ruling.
Is there money to claim? No. There is no settlement, no fund and no claim form — and after two and a half years of dismissal, the litigation has only just been revived on a procedural point. Any dollar figure you see quoted for this case is an attorney's projection, not a paid amount.
⚖️ REVIVED ON APPEAL — On July 13, 2026 the Second Circuit vacated the exclusion of three of five plaintiff experts and sent 500+ dismissed cases back to Judge Cote. No trial date, no settlement, and the defense is seeking rehearing.
Your Case Details
Answer a few questions to see your estimated range.
Higher-tier injuries qualify for higher settlement tiers.
Estimated Settlement Tier
$105,000 — $195,000
Mass tort settlements use injury-severity tiers. Most MDLs have published payment matrices — your tier depends on diagnosis + exposure proof.
Editorially Reviewed — Content reviewed for accuracy using published legal research, government data, and verified court records. See our methodology
Reviewed by Leonard Goldberg, Editor · Last updated
Tylenol Autism Litigation — Back From Dismissal, Not Won
Prenatal Tylenol / acetaminophen use during pregnancy allegedly causes autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) in children. Defendants: Johnson & Johnson, Walmart, Costco, CVS, Rite Aid, Walgreens, Procter & Gamble (store-brand manufacturers/retailers). The federal Tylenol lawsuit cases are consolidated in MDL 3043 in the Southern District of New York.
The turning point: In January 2024, Judge Denise Cote (S.D.N.Y.) excluded all five of the plaintiffs' general-causation experts under FRE 702 and granted summary judgment, effectively ending MDL 3043. On July 13, 2026, the U.S. Court of Appeals for the Second Circuit vacated that exclusion for three of the five experts in Rutledge v. Walgreen Co. (consolidated with Phippen) and remanded. Writing for the panel, Circuit Judge Guido Calabresi held that the district court had crossed the line from gatekeeper to decision-maker: the Daubert inquiry belongs on “principles and methodology, not on the conclusions they generate,” and the court had instead become the “arbiter of which points in the debate are more persuasive; that is the role of the jury.” Two experts remain excluded, and that part of the ruling was affirmed.
What this does NOT mean. No court has found that acetaminophen causes autism — the ruling was about who decides scientific disputes, not about who is right. The cases are back before Judge Cote with no trial date and no settlement framework. Kenvue has said it will renew its challenge to the experts on remand and has sought an extension to petition for rehearing en banc. Kenvue and defendants including Walmart, CVS, Walgreens and Target have since filed that request, urging the Second Circuit to revisit its July 13 ruling; the appeals court rarely grants such requests, and until it rules the remand cannot fully get under way. The science remains genuinely contested: a 2024 JAMA sibling-control study of more than two million children and a January 2026 Lancet review of 43 studies both failed to find a causal link. The FDA began a label-change process for acetaminophen in pregnancy in September 2025, but as of August 2026 that change had not yet appeared on marketed labels.
Tylenol Autism FAQs
Is the Tylenol autism lawsuit still active in 2026?
It is active again — but only just. The federal MDL was dismissed in January 2024 and revived on July 13, 2026, when the Second Circuit vacated the exclusion of three of the five plaintiff experts and remanded 500+ cases to Judge Cote. There is no trial date, no settlement, and the defense is seeking rehearing en banc: Kenvue and defendants including Walmart, CVS, Walgreens and Target have filed a request urging the Second Circuit to revisit its July 13 ruling.
Why were the plaintiffs' experts excluded?
Judge Cote ruled in January 2024 that all five experts' causation methodologies failed FRE 702 as amended in 2023. The Second Circuit disagreed as to three of them, holding that the district court had weighed which side was more persuasive — a jury function — rather than assessing methodology. The exclusion of the remaining two experts was upheld, so the plaintiffs go back with a narrower expert case than they started with.
Does the 2025 FDA notice change anything?
Less than the headlines suggested. The FDA initiated a label-change process in September 2025 regarding acetaminophen use in pregnancy. As of August 2026 the change had not appeared on marketed product labels. A regulatory process is not a causation finding, and it does not resolve the scientific dispute at the center of this litigation.
What dosage of Tylenol qualifies for this lawsuit?
Claims focus on regular/heavy use during pregnancy — typically 3+ times per week or across multiple trimesters. Occasional use for fever generally doesn't qualify. Medical records + pregnancy logs + OB-GYN notes are key evidence.
Does generic acetaminophen count?
Yes — all acetaminophen brands including store brands are in scope. Defendants include retailers + manufacturers of generic acetaminophen (Walmart, Costco, CVS, Rite Aid, Walgreens).
If the appeal fails, can I still file?
State-court claims exist independently of the federal MDL and follow state law on both limitation periods and causation standards — some states apply a less restrictive expert standard than the federal courts. Whether that route is realistic depends heavily on your state and on when the child was diagnosed, which is a question for an attorney licensed there. Separately, the State of Texas has its own case: Attorney General Ken Paxton sued Kenvue, the Tylenol maker, under Texas's Deceptive Trade Practices Act, alleging it hid Tylenol's supposed links to autism and ADHD, and a Panola County judge denied Kenvue's bid to dismiss that suit in a ruling reported on February 26, 2026. It is a state enforcement action, not a claim individual families can join.
What is the timeline if the MDL is reinstated?
Slowly. On remand, the defense has said it will challenge the experts again, and the case still needs a Rule 702 ruling, then discovery, then a bellwether schedule. A realistic trial horizon is 2028 or later, and a petition for rehearing en banc could add months before the remand even begins in earnest. So when will the Tylenol autism lawsuit be settled? Nobody can say: there has been no settlement in this litigation, and no bellwether trials have been scheduled.
What's the potential settlement value?
Nobody knows, and anyone who quotes you a number is guessing. There have been no verdicts, no bellwether trials and no settlement in this litigation — the case has spent the last two and a half years dismissed. Figures in the $50,000–$500,000 range circulate on law-firm pages as projections; they are not based on any amount ever paid in an acetaminophen-autism case.